|
시장보고서
상품코드
2024604
혈당 측정 스트립 시장 보고서 : 유형, 기술, 유통 채널, 최종사용자, 지역별(2026-2034년)Blood Glucose Test Strips Market Report by Type, Technology (Glucose Dehydrogenase, Glucose Oxidase ), Distribution Channel, End User, and Region 2026-2034 |
||||||
세계의 혈당 측정 스트립 시장 규모는 2025년에 143억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 259억 달러에 달하며, 2026-2034년에 CAGR 6.60%로 성장할 것으로 예측하고 있습니다.
혈당 측정 스트립은 혈당 수치를 모니터링하고 당뇨병 증상을 관리하는 데 사용되는 작은 일회용 플라스틱 또는 종이로 만든 작은 일회용 스트립을 말합니다. 이들은 폴리올레핀, 폴리아미드, 폴리설폰, 셀룰로오스 소재를 사용하여 제조됩니다. 혈당 측정 스트립은 친수성 층, 접착층, 센서, 효소, 전극층 등 여러 구성 요소로 구성되어 있습니다. 또한 혈액 샘플의 포도당과 반응하여 혈당치를 나타내는 포도당 산화효소가 스며들어 있습니다. 이 외에도 혈당 측정 스트립은 사용하기 쉽고 비용 효율적이며 매일 사용할 수 있습니다. 그 결과, 고혈당 및 저혈당을 식별하고, 당뇨병 치료 효과를 모니터링하며, 저혈당 및 고혈당 발생 위험을 줄이는 데 도움이 됩니다.
혈당 측정 스트립 시장 동향:
특히 고령화 인구층의 당뇨병 유병률 증가로 인해 시장 전망은 더욱 밝아지고 있습니다. 이에 따라 혈당 측정 스트립은 집에서 정기적으로 혈당을 측정하는 데 널리 활용되고 있으며, 검사 기관을 방문할 필요가 없어져 시장 성장을 촉진하고 있습니다. 또한 혈당 측정기의 접근성, 취급의 편리성, 그리고 높은 정확도로 인해 제 2형 당뇨병 환자들 사이에서 제품이 널리 보급되고 있는 것도 시장 성장에 기여하고 있습니다. 또한 신종 코로나바이러스 감염증(COVID-19) 팬데믹 기간 중 혈당 측정기, 테스트 스트립 등 소모품에 대한 수요와 온라인 판매가 크게 증가했습니다. 이는 예방 조치로, 그리고 감염 후 증상을 기록하기 위해 환자 및 일반인의 혈당치를 지속적으로 모니터링해야 할 필요성이 증가함에 따라 시장 성장을 더욱 촉진하고 있습니다. 이 외에도 바이오메디컬 엔지니어링 분야의 광범위한 연구개발(R&D) 활동, 생활습관 및 식습관 변화, 당뇨병과 그 예방법에 대한 일반 대중의 인식 제고에 초점을 맞춘 다양한 정부 정책의 시행 등이 시장 성장을 촉진할 것으로 예상됩니다.
이 보고서에서 답변하는 주요 질문
- 세계 혈당 측정용 테스트 스트립 시장은 지금까지 어떻게 성장해 왔으며, 향후 수년간 어떻게 성장하는가?
- COVID-19는 세계의 혈당 측정 테스트 스트립 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 시장 유형별 시장 분석은?
- 기술별로 보면 시장 분석은 어떻게 이루어지는가?
- 유통 채널별 시장 현황은?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계의 혈당 측정 스트립 시장의 구조는 무엇이며 주요 기업은 어디인가?
- 이 업계의 경쟁은 얼마나 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 혈당 측정 스트립 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 유통 채널별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porters Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSA 26.05.18The global blood glucose test strips market size reached USD 14.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.60% during 2026-2034.
Blood glucose test strips refer to small, disposable plastic or paper strips used to monitor blood glucose levels and control diabetes symptoms. They are manufactured using polyolefin, polyamide, polysulfone and cellulose materials. A blood glucose test strip comprises several components, such as hydrophilic, adhesive, sensors, enzymes and electrode layers. They are also soaked in glucose oxidase that reacts with glucose present in the blood sample to indicate sugar levels. Apart from this, blood glucose test strips are easy to use, cost-effective, and can be used daily. Consequently, they assist in identifying high or low blood sugar levels, monitoring the effectiveness of diabetes treatment, and lowering the risks of developing hypoglycemia and/or hyperglycemia.
BLOOD GLUCOSE TEST STRIPS MARKET TRENDS:
The increasing prevalence of diabetes, especially among the growing geriatric population is creating a positive outlook for the market. In line with this, blood glucose test strips are widely used to test sugar levels regularly at home, while eliminating the need to visit a diagnostic laboratory, which is supporting the market growth. Additionally, the widespread product adoption among type-2 diabetic patients due to the easy availability of glucometers, convenient handling, and the level of accuracy provided by the machine are favoring the market growth. Moreover, the demand and online sales for blood glucose monitoring devices and consumables, such as test strips significantly surged during the coronavirus disease (COVID-19) pandemic. This can be attributed to the increasing need to continuously monitor sugar levels in patients and commoners both as a precautionary measure and to record post-infection symptoms, which, in turn, is augmenting the market growth. Other factors, including extensive research and development (R&D) activities in the field of biomedical engineering, evolving lifestyles and eating habits, and the implementation of various government initiatives focusing on educating the masses regarding diabetes and its preventive measures, are anticipated to drive the market toward growth.
KEY MARKET SEGMENTATION:
Breakup by Type:
- Thick Film Electrochemical Films
- Thin Film Electrochemical Films
- Optical Strips
Breakup by Technology:
- Glucose Dehydrogenase (GDH)
- Glucose Oxidase (GOD)
Breakup by Distribution Channel:
- Online
- Offline
Breakup by End User:
- Individuals
- Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global blood glucose test strips market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global blood glucose test strips market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the distribution channel?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global blood glucose test strips market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Blood Glucose Test Strips Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Thick Film Electrochemical Films
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Thin Film Electrochemical Films
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Optical Strips
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Glucose Dehydrogenase (GDH)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Glucose Oxidase (GOD)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Online
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Offline
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Individuals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 77 Elektronika Kft.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Abbott Laboratories
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 AgaMatrix Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Ascensia Diabetes Care Holdings AG (PHC Holdings)
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 B. Braun Melsungen Aktiengesellschaft
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 SWOT Analysis
- 15.3.6 Bioland Technology Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Bionime Corporation
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 BTNX Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Microlife Corporation (Midas Company Limited)
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Norditalia Group S.R.L.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Rossmax International Ltd.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.12 Unistrip Technologies LLC
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.1 77 Elektronika Kft.
